Evidence map›Paper›PMID 32204741›Full record

ReviewPsychological medicine2020

A mechanistic model for individualised treatment of anxiety disorders based on predictive neural biomarkers.

Anne-Kathrin Brehl, Nils Kohn, Aart Herman Schene, Guillen Fernández

Open access · hybridAbstract readReview
In one paragraph

Review in Psychological medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. A Proton Magnetic Resonance Spectroscopy (International journal of molecular sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. COBMC psychiatry · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anne-Kathrin BrehlRadboud University, Donders Institute for Brain Cognition and Behaviour, Nijmegen, The Netherlands.ORCID 0000-0002-1499-1373
Nils KohnRadboud University, Donders Institute for Brain Cognition and Behaviour, Nijmegen, The Netherlands.ORCID 0000-0002-1954-2753
Aart Herman ScheneRadboud University Medical Center, Nijmegen, The Netherlands.
Guillen FernándezRadboud University, Donders Institute for Brain Cognition and Behaviour, Nijmegen, The Netherlands.ORCID 0000-0002-5522-0604
Radboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased amygdala responsiveness is the hallmark of fear and a characteristic across patients with anxiety disorders. The amygdala is embedded in a complex regulatory circuit. Multiple different mechanisms may elevate amygdala responsiveness and lead to the occurrence of an anxiety disorder. While top-down control by the prefrontal cortex (PFC) downregulates amygdala responses, the locus coeruleus (LC) drives up amygdala activation via noradrenergic projections. This indicates that the same fearful phenotype may result from different neural mechanisms. We propose a mechanistic model that defines three different neural biomarkers causing amygdala hyper-responsiveness in patients with anxiety disorders: (a) inherent amygdala hypersensitivity, (b) low prefrontal control and (c) high LC drive. First-line treatment for anxiety disorders is exposure-based cognitive behavioural therapy, which strengthens PFC recruitment during emotion regulation and thus targets low-prefrontal control. A treatment response rate around 50% (Loerinc et al., 2015, Clinical Psychological Reviews, 42, 72-82) might indicate heterogeneity of underlying neurobiological mechanisms among patients, presumably leading to high variation in treatment benefit. Transforming insights from cognitive neuroscience into applicable clinical heuristics to categorise patients based on their underlying biomarker may support individualised treatment selection in psychiatry. We review literature on the three anxiety-related mechanisms and present a mechanistic model that may serve as a rational for pathology-based diagnostic and biomarker-guided treatment selection in psychiatry.

Indexed as

AmygdalaAnxiety DisordersBiomarkersBrain MappingCognitive Behavioral TherapyEmotionsFearHumansLocus CoeruleusMagnetic Resonance ImagingNeural PathwaysPrefrontal CortexStress Disorders, Post-TraumaticBiomarkersamygdalaAnxietyexposure therapygeneralized anxiety disorderlocus coeruleusnoradrenalinepanic disorderPFCPTSDsocial phobia

Identifiers

PMID32204741
PMCPMC7168651
OpenAlexW3012894460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.